Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 2,380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380 F1: Annual non-employee director award. F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 4,190 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,190 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director award.
F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2017 Filed May 5, 2017 20:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-17-017062 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $122.32 | $61,160.00 |
DisclosureSEC source: 0001127602-17-017062 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:08 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-17-017062 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 20:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-17-014587 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 750 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 20:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-17-014587 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 20:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $122.00 | $91,500.00 |
DisclosureSEC source: 0001127602-17-014587 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 20:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-17-014587 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 20:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $122.00 | $61,000.00 |
DisclosureSEC source: 0001127602-17-014587 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 20:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-17-014587 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-17-010245 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,750 Underlying: Common Stock · 750 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-17-010245 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $147.19 | $110,392.50 |
DisclosureSEC source: 0001127602-17-010245 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-17-010245 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $147.19 | $73,595.00 |
DisclosureSEC source: 0001127602-17-010245 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:07 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-17-010245 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:14 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-17-003880 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 750 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:14 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-17-003880 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:14 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $165.10 | $123,825.00 |
DisclosureSEC source: 0001127602-17-003880 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:14 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $165.10 | $82,550.00 |
DisclosureSEC source: 0001127602-17-003880 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:14 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-17-003880 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:14 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-17-003880 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:06 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-17-001279 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common Stock · 750 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:06 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-17-001279 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:06 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $145.89 | $109,417.50 |
DisclosureSEC source: 0001127602-17-001279 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:06 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $54.77 | $41,077.50 |
DisclosureSEC source: 0001127602-17-001279 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:06 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $145.89 | $72,945.00 |
DisclosureSEC source: 0001127602-17-001279 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:06 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-17-001279 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 12:16 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-070505 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 Read SEC document |
| December 16, 2016 Filed Jan 30, 2017 11:41 UTC Amendment | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-002758 · form4a.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 F1 · shares: This amendment is being filed to correct an error in the original filing, which over stated the number of shares gifted by 10 shares. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:15 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-16-068982 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 750 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:15 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-16-068982 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:15 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $126.96 | $95,220.00 |
DisclosureSEC source: 0001127602-16-068982 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:15 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $51.77 | $38,827.50 |
DisclosureSEC source: 0001127602-16-068982 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:15 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $126.96 | $63,480.00 |
DisclosureSEC source: 0001127602-16-068982 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:15 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-16-068982 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-16-066157 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-16-066157 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,750 Underlying: Common Stock · 750 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $113.42 | $56,710.00 |
DisclosureSEC source: 0001127602-16-066157 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-16-066157 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $113.42 | $85,065.00 |
DisclosureSEC source: 0001127602-16-066157 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:04 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $51.77 | $38,827.50 |
DisclosureSEC source: 0001127602-16-066157 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 06, 2016 Filed Oct 11, 2016 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 750 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-16-064620 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 750 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 06, 2016 Filed Oct 11, 2016 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-16-064620 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 06, 2016 Filed Oct 11, 2016 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 750 | $121.22 | $90,915.00 |
DisclosureSEC source: 0001127602-16-064620 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 06, 2016 Filed Oct 11, 2016 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $121.22 | $60,610.00 |
DisclosureSEC source: 0001127602-16-064620 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,855 F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 06, 2016 Filed Oct 11, 2016 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 750 | $51.77 | $38,827.50 |
DisclosureSEC source: 0001127602-16-064620 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| October 06, 2016 Filed Oct 11, 2016 20:10 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-16-064620 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| July 01, 2016 Filed Jan 22, 2019 22:01 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 500 | $0.00 Strike: $51.77 | $0.00 |
DisclosureSEC source: 0001127602-19-002480 · form4.xml · derivative · entry 7 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 500 shares Expires 2020-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| July 01, 2016 Filed Jan 22, 2019 22:01 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 500 | $108.89 | $54,445.00 |
DisclosureSEC source: 0001127602-19-002480 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F2 · kind: This transaction was inadvertently omitted from the reporting person's filings due to an administrative error. Read SEC document |
| July 01, 2016 Filed Jan 22, 2019 22:01 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 500 | $51.77 | $25,885.00 |
DisclosureSEC source: 0001127602-19-002480 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F2 · kind: This transaction was inadvertently omitted from the reporting person's filings due to an administrative error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.